{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:27:43Z","timestamp":1775791663086,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":262,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.074","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:29:20Z","timestamp":1583432960000},"page":"3086-3095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fatal outcomes following immunization errors as reported to the EudraVigilance: A case series"],"prefix":"10.1016","volume":"38","author":[{"given":"Christina E.","family":"Hoeve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartini","family":"Gadroen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel S.G.","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C.J.M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine M.J.M.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.074_b0005","unstructured":"World Health Organization. Vaccine safety basics - elearning course. Module 1: History of vaccine development 2018. Available from: https:\/\/vaccine-safety-training.org\/history-of-vaccine-development.html."},{"key":"10.1016\/j.vaccine.2020.02.074_b0010","doi-asserted-by":"crossref","unstructured":"Plotkin S, Plotkin S. Chapter 1: A short history of vaccination. Plotkin's Vaccines. 7th ed. Elsevier; 2018. p. 1\u201315.","DOI":"10.1016\/B978-0-323-35761-6.00001-8"},{"key":"10.1016\/j.vaccine.2020.02.074_b0015","unstructured":"World Health Organization. Vaccines and diseases 2019. Available from: https:\/\/www.who.int\/immunization\/diseases\/en\/."},{"key":"10.1016\/j.vaccine.2020.02.074_b0020","unstructured":"World Health Organization, UNICEF, World Bank. State of the world\u2019s vaccines and immunization. Geneva: World Health Organization; 2009."},{"key":"10.1016\/j.vaccine.2020.02.074_b0025","unstructured":"Pharmacovigilance Risk Assessment Committee. Good practice guide on recording, coding, reporting and assessment of medication errors. EMA\/762563\/2014. European Medicines Agency; 2015."},{"key":"10.1016\/j.vaccine.2020.02.074_b0030","unstructured":"European Medicines Agency and Heads of Medicines Agencies. Guideline on good pharmacovigilance practices (GVP): Module VI - collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev 2). European Medicines Agency; 2017."},{"issue":"48","key":"10.1016\/j.vaccine.2020.02.074_b0035","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1016\/j.vaccine.2014.09.018","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013","volume":"32","author":"Haber","year":"2014","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2020.02.074_b0040","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.vaccine.2015.01.080","article-title":"Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014","volume":"33","author":"Haber","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0b013e3181ff9795","article-title":"Adverse events following trivalent inactivated influenza vaccination in children: analysis of the vaccine adverse event reporting system","volume":"30","author":"Muhammad","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.074_b0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jpids\/piu034","article-title":"Post-licensure surveillance of trivalent live-attenuated influenza vaccine in children aged 2\u201318 years, vaccine adverse event reporting system, United States, July 2005-June 2012","volume":"4","author":"Haber","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.074_b0055","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1097\/INF.0000000000001201","article-title":"Adverse events after MMR or MMRV vaccine in infants under nine months old","volume":"35","author":"Woo","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"28","key":"10.1016\/j.vaccine.2020.02.074_b0060","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2015.05.006","article-title":"Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000\u20132013","volume":"33","author":"Hibbs","year":"2015","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2020.02.074_b0065","first-page":"2049","article-title":"Medication errors reported to the vaccine adverse event reporting system (VAERS)","volume":"2002","author":"Varricchio","year":"2002","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2020.02.074_b0070","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1016\/j.vaccine.2018.11.003","article-title":"Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: a descriptive study","volume":"36","author":"Hoeve","year":"2018","journal-title":"Vaccine"},{"issue":"53","key":"10.1016\/j.vaccine.2020.02.074_b0075","first-page":"74","article-title":"Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending as regards pharmacovigilance, Directive 2001\/ 83\/EC on the Community code relating to medicinal products for human use","volume":"L348","author":"European Union","year":"2010","journal-title":"Off J Eur Union"},{"key":"10.1016\/j.vaccine.2020.02.074_b0080","unstructured":"Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs) \u2013 E2B(R3) Data Elements and Message Specification. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; 2016."},{"key":"10.1016\/j.vaccine.2020.02.074_b0085","unstructured":"Council for International Organization of Medical Sciences (CIOMS). Development and Rational use of Standardised MedDRA Queries (SMQs): Retrieving Adverse Drug Reactions with MedDRA. 2nd ed.; 2016."},{"key":"10.1016\/j.vaccine.2020.02.074_b0090","unstructured":"The World Bank. World Bank list of economies 2019 [1 June 2019]. Available from: databank.worldbank.org."},{"key":"10.1016\/j.vaccine.2020.02.074_b0095","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI) - User manual for the revised WHO classification. 2018."},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.074_b0100","first-page":"606","article-title":"Contamination of reconstituted multidose measles vaccine vial and toxic shock syndrome in Tamilnadu","volume":"45","author":"Parthasarathy","year":"2008","journal-title":"Indian Pediatr."},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.074_b0105","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciu970","article-title":"Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation","volume":"60","author":"Bhalla","year":"2015","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2020.02.074_b0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212688","article-title":"Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient","author":"Costa","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000000507","article-title":"Risk of rotavirus vaccination for children with SCID","volume":"34","author":"Klinkenberg","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.02.074_b0120","unstructured":"Public Health England. Shingles (herpes zoster). The Green Book 2014; chapter 28a 2014. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/357155\/Green_Book_Chapter_28a_v0_5.pdf."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.02.074_b0125","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1007\/s00247-010-1650-6","article-title":"MRI findings in an infant with vaccine-associated paralytic poliomyelitis","volume":"40","author":"Lopes Ferraz-Filho","year":"2010","journal-title":"Pediatr Radiol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.074_b0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.mayocp.2016.04.010","article-title":"Risk of disseminated disease in immunosuppressed patients receiving live zoster vaccine","volume":"91","author":"Young","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"10.1016\/j.vaccine.2020.02.074_b0135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.1947.62880150001007","article-title":"Fatal allergic reaction due to influenza vaccine","volume":"133","author":"Curphey","year":"1947","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2020.02.074_b0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203311429556","article-title":"Systemic lupus erythematosus following HPV immunization or infection?","volume":"21","author":"Soldevilla","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2020.02.074_b0145","first-page":"423","article-title":"Fulminant hepatitis and multisystem organ failure following yellow fever vacciantion:desciprtion of a fatal case","volume":"42","author":"O'Conghaile","year":"2014","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-016-1629-y","article-title":"Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis","volume":"133","author":"Morfopoulou","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.vaccine.2020.02.074_b0155","unstructured":"Centers for Disease Control and Prevention (CDC). International Notes Certification of Poliomyelitis Eradication \u2013 the Americas, 1994. Morb Mort Week Rep 1994; 43(39):720\u20132."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.02.074_b0160","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: the role of age at the time of vacciantion","volume":"192","author":"Simonsen","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.074_b0165","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2014.01.054","article-title":"On the relationship between human papilloma virus vaccine and autoimmune diseases","volume":"13","author":"Pellegrino","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(89)90010-8","article-title":"Failure of rabies postexposure treatment in Thailand","volume":"7","author":"Wilde","year":"1989","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.074_b0175","first-page":"702","article-title":"Rabies Encephalitis","volume":"44","author":"Mohite","year":"2007","journal-title":"Indian Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.074_b0180","first-page":"65","article-title":"Failures of post-exposure rabies prophylaxis","volume":"16","author":"Wilde","year":"2007","journal-title":"Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.074_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000243","article-title":"Rabies post-exposure prophylaxis in the philippines: health status of patients having received purified equine F(ab\u2019)2 fragment rabies immunoglobulin (Favirab)","volume":"2","author":"Quiambao","year":"2008","journal-title":"PLoS Negl Trop Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.074_b0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0255-0857.81786","article-title":"Fatal rabies despite post-exposure prophylaxis","volume":"29","author":"Deshmukh","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.074_b0195","article-title":"The relevance of rabies to today's military","volume":"4","author":"Cooper","year":"2012","journal-title":"US Army Med Dep J"},{"key":"10.1016\/j.vaccine.2020.02.074_b0200","unstructured":"Ogola E, Recuenco S, Niezgoda M, Lokoel G, Gentile A, Oketch S, et al. Atypical rabies: A case report from a rabies outbreak in Kenya 2012."},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.074_b0205","first-page":"210","article-title":"Rabies: A killer disease-II","volume":"17","author":"Salahuddin","year":"2013","journal-title":"Anaesth, Pain Intenstive Care"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.074_b0210","first-page":"61","article-title":"Case report: evidence of rise in rabies cases in southern malawi \u2013 better preventative measures are urgently required","volume":"24","author":"Depani","year":"2012","journal-title":"Malawi Med J"},{"key":"10.1016\/j.vaccine.2020.02.074_b0215","unstructured":"Pue H, Turabelidze G, Patrick S, Grim A, Bell C, Reese B, et al. Human Rabies - Missouri, 2008. Centers for Disease Control and Prevention MMWR Weekly, November 6, 2009 2009;58(43):1207\u20139."},{"key":"10.1016\/j.vaccine.2020.02.074_b0220","unstructured":"Egyptian Drug Authority. A case of death in Egypt after the administration of Rabies vaccine: case report. Egypt Pharm Vigilance Cent Newslett 5. 2013;4:1."},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.074_b0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.vaccine.2017.11.083","article-title":"Safety of vaccines that have been kept outside of recommended temperatures: reports to the Vaccine Adverse Event Reporting System (VAERS), 2008\u20132012","volume":"36","author":"Hibbs","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.074_b0230","first-page":"477","article-title":"Death of children after measles vaccination","volume":"45","author":"John","year":"2008","journal-title":"Indian Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.074_b0235","first-page":"479","article-title":"Measles vaccine deaths: The IAP-COI stand","volume":"45","author":"Amdekar","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2020.02.074_b0240","unstructured":"World Health Organization. Immunization in Practice - Module 2: The vaccine cold chain; 2015."},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4161\/hv.26200","article-title":"Fatal varicella due to the vaccine-strain varicella-zoster virus","volume":"10","author":"Leung","year":"2014","journal-title":"Hum Vaccines Immunotherap"},{"issue":"9576","key":"10.1016\/j.vaccine.2020.02.074_b0250","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0140-6736(07)60848-4","article-title":"Varicella vaccine and fatal outcome in leukaemia","volume":"369","author":"Ulloa-Gutierrez","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.074_b0255","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/21645515.2014.1004034","article-title":"Letter to the Editor: Fatal varicella due to the vaccine-strain varicella-zoster virus","volume":"11","author":"Woo","year":"2015","journal-title":"Hum Vaccines Immunotherap"},{"issue":"27","key":"10.1016\/j.vaccine.2020.02.074_b0260","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1016\/j.vaccine.2018.05.078","article-title":"Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection","volume":"36","author":"Alexander","year":"2018","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2020.02.074_b0265","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.vaccine.2018.08.021","article-title":"Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus","volume":"36","author":"Hadjipanayis","year":"2018","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2020.02.074_b0270","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1016\/j.vaccine.2018.07.024","article-title":"Reasons for non-vaccination and incomplete vaccinations among children in Pakistan","volume":"36","author":"Riaz","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.074_b0275","unstructured":"European Medicines Agency. QRD recommendations on pack design and labelling for centrally authorised non-prescription human medicinal products. 2011."},{"issue":"21","key":"10.1016\/j.vaccine.2020.02.074_b0280","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.vaccine.2011.03.044","article-title":"Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations \u2013 a population based study of 969,519 vaccination events","volume":"29","author":"Wilson","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.074_b0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pds.4141","article-title":"Vaccination and unexplained sudden death risk in Taiwanese infants","volume":"26","author":"Huang","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"13","key":"10.1016\/j.vaccine.2020.02.074_b0290","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2012.01.043","article-title":"Reanalyses of case-control studies examining the temporal association between sudden infant death syndrome and vaccination","volume":"30","author":"Kuhnert","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.074_b0295","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.vaccine.2006.07.027","article-title":"Sudden infant death syndrome: no increased risk after immunisation","volume":"25","author":"Vennemann","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.074_b0300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.vaccine.2017.12.065","article-title":"Sudden infant death syndrome, attention-deficit\/hyperactivity disorder and vaccines: Longitudinal population analyses","volume":"36","author":"Yang","year":"2018","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2020.02.074_b0305","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2007.02.077","article-title":"Do immunisations reduce the risk for SIDS? A meta-analysis","volume":"25","author":"Vennemann","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.074_b0310","unstructured":"Institute of Medicine (US) Immunization Safety Review Committee. Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy. Washington (DC): National Academies Press; 2003."},{"key":"10.1016\/j.vaccine.2020.02.074_b0315","unstructured":"Centers for Disease Control and Prevention. Vaccines and Sudden Infant Death Syndrome (SIDS) 2018 [updated 16 October 2018. Available from: https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/sids.html."},{"key":"10.1016\/j.vaccine.2020.02.074_b0320","unstructured":"Corwin M. Sudden infant death syndrome: Risk factors and risk reduction strategies UpToDate2019 [updated 10 July 2019. Available from: https:\/\/www.uptodate.com."},{"key":"10.1016\/j.vaccine.2020.02.074_b0325","unstructured":"World Health Organization. Global vaccine safety blueprint. 2012."},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.074_b0330","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.vaccine.2018.02.012","article-title":"Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000\u20132015","volume":"36","author":"Lei","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.074_b0335","unstructured":"World health Organization. Global Vaccine Safety Blueprint 2.0 Background Research. 2019."},{"issue":"44","key":"10.1016\/j.vaccine.2020.02.074_b0340","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2013.08.087","article-title":"Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use","volume":"31","author":"Tozzi","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.074_b0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.12688\/f1000research.13694.1","article-title":"Revised World Health Organization (WHO)'s causality assessment of adverse events following immunization - a critique","author":"Puliyel","year":"2018","journal-title":"F1000Research"},{"issue":"51","key":"10.1016\/j.vaccine.2020.02.074_b0350","first-page":"7","article-title":"Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data","volume":"2010","author":"McNeil","year":"2010","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.074_b0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.619","article-title":"The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990\u20131997","volume":"10","author":"Silvers","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"41","key":"10.1016\/j.vaccine.2020.02.074_b0360","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1016\/j.vaccine.2016.08.062","article-title":"Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance","volume":"34","author":"Gadroen","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:13Z","timestamp":1759401733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":72,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20303182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal outcomes following immunization errors as reported to the EudraVigilance: A case series","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}